BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12449099)

  • 1. Nondopaminergic neurons in Parkinson's disease.
    Hirsch EC; Orieux G; Muriel MP; Francois C; Feger J
    Adv Neurol; 2003; 91():29-37. PubMed ID: 12449099
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?
    Kish SJ
    Adv Neurol; 2003; 91():39-49. PubMed ID: 12442662
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional neuroanatomy of the basal ganglia in Parkinson's disease.
    Wichmann T; DeLong MR
    Adv Neurol; 2003; 91():9-18. PubMed ID: 12442660
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential nondopaminergic drugs for Parkinson's disease.
    Silverdale MA; Fox SH; Crossman AR; Brotchie JM
    Adv Neurol; 2003; 91():273-91. PubMed ID: 12442686
    [No Abstract]   [Full Text] [Related]  

  • 5. New insights in Parkinson's disease therapy: can levodopa-induced dyskinesia ever be manageable.
    Hadj Tahar A; Grondin R; Grégoire L; Calon F; Di Paolo T; Bédard PJ
    Adv Neurol; 2003; 91():51-64. PubMed ID: 12442663
    [No Abstract]   [Full Text] [Related]  

  • 6. The functional anatomy of noradrenergic neurons in Parkinson's disease.
    Soldani P; Fornai F
    Funct Neurol; 1999; 14(2):97-109. PubMed ID: 10399622
    [No Abstract]   [Full Text] [Related]  

  • 7. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology.
    Braak H; de Vos RA; Bohl J; Del Tredici K
    Neurosci Lett; 2006 Mar; 396(1):67-72. PubMed ID: 16330147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of the extranigral aspects of Parkinson disease.
    Lim SY; Fox SH; Lang AE
    Arch Neurol; 2009 Feb; 66(2):167-72. PubMed ID: 19204152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease is a neuropsychiatric disorder.
    Agid Y; Arnulf I; Bejjani P; Bloch F; Bonnet AM; Damier P; Dubois B; François C; Houeto JL; Iacono D; Karachi C; Mesnage V; Messouak O; Vidailhet M; Welter ML; Yelnik J
    Adv Neurol; 2003; 91():365-70. PubMed ID: 12442695
    [No Abstract]   [Full Text] [Related]  

  • 10. Dopamine agonists, sleep disorders, and driving in Parkinson's disease.
    Uitti RJ; Wszolek ZK
    Adv Neurol; 2003; 91():343-9. PubMed ID: 12442692
    [No Abstract]   [Full Text] [Related]  

  • 11. Introduction. Dopamine and Parkinson's disease.
    Triarhou LC
    Adv Exp Med Biol; 2002; 517():1-14. PubMed ID: 12580304
    [No Abstract]   [Full Text] [Related]  

  • 12. p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.
    Mogi M; Kondo T; Mizuno Y; Nagatsu T
    Neurosci Lett; 2007 Feb; 414(1):94-7. PubMed ID: 17196747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous regeneration in Parkinson's disease: do we need orthotopic dopaminergic neurogenesis?
    Hermann A; Storch A
    Stem Cells; 2008 Nov; 26(11):2749-52. PubMed ID: 18719222
    [No Abstract]   [Full Text] [Related]  

  • 14. Thirty years of dopamine research.
    Carlsson A
    Adv Neurol; 1993; 60():1-10. PubMed ID: 8093570
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential diagnosis of parkinsonism.
    Facca AG; Koller WC
    Adv Neurol; 2003; 91():383-96. PubMed ID: 12442697
    [No Abstract]   [Full Text] [Related]  

  • 16. The globus pallidus pars externa and Parkinson's disease. Ready for prime time?
    Obeso JA; Rodriguez-Oroz MC; Javier Blesa F; Guridi J
    Exp Neurol; 2006 Nov; 202(1):1-7. PubMed ID: 16920102
    [No Abstract]   [Full Text] [Related]  

  • 17. Transmitter receptor alterations in Parkinson's disease.
    Calne DB; Stoessl AJ
    Adv Neurol; 1987; 45():45-9. PubMed ID: 2881449
    [No Abstract]   [Full Text] [Related]  

  • 18. Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter.
    Hartmann A; Hunot S; Hirsch EC
    Exp Neurol; 2003 Dec; 184(2):561-4. PubMed ID: 14769349
    [No Abstract]   [Full Text] [Related]  

  • 19. Medications for Parkinson's disease.
    Whitney CM
    Neurologist; 2007 Nov; 13(6):387-8. PubMed ID: 18090719
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid alterations in corticostriatal ensemble coordination during acute dopamine-dependent motor dysfunction.
    Costa RM; Lin SC; Sotnikova TD; Cyr M; Gainetdinov RR; Caron MG; Nicolelis MA
    Neuron; 2006 Oct; 52(2):359-69. PubMed ID: 17046697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.